These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1986891)

  • 21. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
    Heerdt PM; Weiss CI
    Ann Thorac Surg; 1990 Mar; 49(3):463-5. PubMed ID: 2106846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
    Barst RJ
    Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on the hemodynamic effects of prostaglandin E1 prostacyclin, and tolazoline upon elevated pulmonary vascular resistance in neonatal swine.
    Starling MB; Neutze JM; Elliott RL; Elliott RB
    Prostaglandins Med; 1981 Nov; 7(5):349-61. PubMed ID: 7034018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S; Xiao M; Liu Y
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
    Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
    Wilkens H; Guth A; König J; Forestier N; Cremers B; Hennen B; Böhm M; Sybrecht GW
    Circulation; 2001 Sep; 104(11):1218-22. PubMed ID: 11551870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
    Delcroix M; Mélot C; Lejeune P; Leeman M; Naeije R
    Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E1 in pulmonary hypertension of collagen disease.
    Kawahara R; Takezawa J; Mike N; Fukui S; Nishimura M; Tachimori Y; Taenaka N; Yoshiya I
    Crit Care Med; 1987 Sep; 15(9):884-5. PubMed ID: 3621967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
    Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
    Nootens M; Schrader B; Kaufmann E; Vestal R; Long W; Rich S
    Chest; 1995 Jan; 107(1):54-7. PubMed ID: 7813311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery.
    Kermode J; Butt W; Shann F
    Br Heart J; 1991 Aug; 66(2):175-8. PubMed ID: 1883670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
    Kates RA; Zaggy AP; Norfleet EA; Heath KR
    Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.